Eurofins Launches the Second Tranche of a Buy-back Programme of Its Own Shares

Regulatory News: Eurofins (Paris:ERF): Following the announcement on 3 October 2022 to buy-back some of its own shares (ISIN FR0014000MR3) (the "Share Repurchase Plan") and the completion of the

Related Keywords

,Contract Research ,European Parliament ,Biopharma Contract Development ,Euronext Paris Stock Exchange ,Company Extraordinary ,Company Long ,Regulatory News ,Eurofins Scientific ,Share Repurchase Plan ,Extraordinary General Meeting ,Long Term Incentive ,Eurofins ,Aunches ,Second ,Tranche ,Back ,Programme ,Hares ,